RxDoctor Payments Data

John Wu

Physician Assistant · Tulare, CANPI 1023529484

Payments from drug & device makers

$2,505in general payments, 2019–2025

Across 110 payments — averaging $22.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$529
  • GSK$428
  • Regeneron Healthcare Solutions, Inc.$242
  • AstraZeneca$219
  • Amgen$210
  • Lilly USA, LLC$156
  • plus $721 from 15 others

What the payments were for

  • Food & beverage$2,40596%
  • Education$994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,505 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin48$62,357
FarxigaDapagliflozin Propanediol39$44,290
MounjaroTirzepatide38$35,453
OzempicSemaglutide34$31,215
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$18,654
JanuviaSitagliptin Phosphate15$14,594
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,046
Repatha SureclickEvolocumab14$8,495
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$4,830
Albuterol Sulfate HfaAlbuterol Sulfate99$3,841
Valsartan46$2,097
Gabapentin98$1,606
Hydroxyzine Hcl36$936
Atorvastatin Calcium106$750
Bupropion Hcl SrBupropion Hcl18$705

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$111$62,35748 claims
AstraZenecaFarxiga, Breztri Aerosphere$219$54,33656 claims
Lilly USA, LLCMounjaro$156$35,45338 claims
Novo NordiskOzempic$529$31,21534 claims
GSKTrelegy Ellipta$428$18,65429 claims
MerckJanuvia$42$14,59415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Tulare

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →